Hearts & Minds Blog

Providing an Alternative for LDL-C Lowering

Tim Mayleben

President and Chief Executive Officer

Brian Orelli’s recent article in BioWorld Insight, “Avoiding the PCSK9 frenzy with alternative drug targets,” highlights how the focus and… more

Working to Impact the Lives of Millions of Statin Intolerant Patients

Tim Mayleben

President and Chief Executive Officer

I re-joined Roger at Esperion almost a year ago to help people who are at risk for debilitating and life-threatening… more

Posted In: Company News